As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

Experts exploring what other conditions semaglutide, the active ingredient in Wegovy and Ozempic, might help apart from ...

Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial, The Lancet Diabetes ...

1 Semaglutide 2.4 mg is not approved in the US for the treatment of MASH. ESSENCE is a phase 3 trial evaluating the effect of once-weekly subcutaneous semaglutide 2.4 mg in adults with metabolic ...

Two weeks ago, Eli Lilly further extended its leadership position by delivering positive phase 3 ... see how the type 2 diabetes (Mounjaro) and obesity (Zepbound) versions of tirzepatide are ...